A Randomized Controlled Trial Plus a Systematic Review and Meta-Analysis of Published Studies Evaluating a Conventional Prophylactic Regimen of Oral Dexamethasone vs Short-Course Intravenous Dexamethasone in Preventing Paclitaxel-Associated Hypersensitivity Reactions in Patients With Gynecologic Malignancies
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280251320067 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Kofi N Donkor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Loma Linda University Health, Loma Linda, CA, USA. Hauptthemen laut MEDLINE: Paclitaxel, Dexamethasone, Genital Neoplasms, Female, Drug Hypersensitivity. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Hypersensitivity reactions (HSRs) are often encountered in patients receiving paclitaxel infusions. The conventional method, comprising dexamethasone 20 mg (Dex20) taken 12 and 6 hours before paclitaxel plus histamine (H)1 and H2-antagonists administered 30 minutes before paclitaxel, is an effective but cumbersome method in reducing HSRs in gynecologic oncology patients.
Objective
Determine the effectiveness of a simplified premedication method (short-course) comprising Dex20 and H1 and H2 antagonists administered 30 minutes before paclitaxel vs the conventional method in preventing HSRs.
Methods
The effectiveness of the short-course vs the conventional method was investigated via a Randomized Controlled Trial (RCT) and a Systematic Review and Meta-analysis by searching PubMed, EMBASE, and the Cochrane Library from inception to December 4, 2024. Primary outcomes were any-grade and grade ≥3 HSRs. Differences in effectiveness were presented as risk difference (RD) using the Mantel–Haenszel estimation and expressed with 95% confidence intervals (CIs). P -values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Loma Linda University Health, Loma Linda, CA, USA.
- School of Pharmacy, Loma Linda University, Loma Linda, CA, USA.
- Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, School of Medicine, Loma Linda University, Loma Linda, CA, USA.
ORCID-Profile: Kofi N Donkor
Zitieren
APA
Donkor, K. N., Jang, H., Selim, J. H., Ioffe, Y. J., & Hong, L. J. (2025). A Randomized Controlled Trial Plus a Systematic Review and Meta-Analysis of Published Studies Evaluating a Conventional Prophylactic Regimen of Oral Dexamethasone vs Short-Course Intravenous Dexamethasone in Preventing Paclitaxel-Associated Hypersensitivity Reactions in Patients With Gynecologic Malignancies. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251320067
Vancouver
Donkor KN, Jang H, Selim JH, Ioffe YJ, Hong LJ. A Randomized Controlled Trial Plus a Systematic Review and Meta-Analysis of Published Studies Evaluating a Conventional Prophylactic Regimen of Oral Dexamethasone vs Short-Course Intravenous Dexamethasone in Preventing Paclitaxel-Associated Hypersensitivity Reactions in Patients With Gynecologic Malignancies. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251320067
BibTeX
@article{Donkor2025,
author = {Donkor, Kofi N and Jang, Hyeree and Selim, Julie Hana and Ioffe, Yevgeniya J and Hong, Linda J},
title = {A Randomized Controlled Trial Plus a Systematic Review and Meta-Analysis of Published Studies Evaluating a Conventional Prophylactic Regimen of Oral Dexamethasone vs Short-Course Intravenous Dexamethasone in Preventing Paclitaxel-Associated Hypersensitivity Reactions in Patients With Gynecologic Malignancies},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280251320067}
}
EUVIMED